Jing Yu

6PUBLICATIONS
5CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 02, 2026
Lipid Metabolic Reprogramming in Lung Cancer: Mechanisms and Therapeutic Targets in the Tumor Microenvironment.

|Mar 26, 2025
Molecular Characteristics of Prognosis and Chemotherapy Response in Breast Cancer: Biomarker Identification Based on Gene Mutations and Pathway.

Liyan Li, Hongwei Lyu, Qian Chen

|Apr 11, 2024
The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.

Shan Wang, Xiaolin Liu, Hongwei Lv

|Feb 15, 2024
Comparative safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis.

Shan Wang, Li Yan, Jing Yu

|Dec 27, 2022
LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma.

Shan Wang, Zhaoxin Chen, Hongwei Lv

|Apr 16, 2022
Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer.

Xiaoting Ma, Yujian Zhang, Cong Wang

Pageof 1

Frequent Collaborators

1 joint publications

Liyan Li

1 joint publications

Hongwei Lyu

1 joint publications

Qian Chen

1 joint publications

Yating Bai